A

Aditxt
D

ADTX

1.72000
USD
-0.08
(-4.44%)
Market Closed
Volume
387
EPS
-92
Div Yield
-
P/E
-0
Market Cap
2,077,640
Related Instruments
ABT
ABT
-0.240
(-0.18%)
131.240 USD
B
BCRX
0.215
(2.07%)
10.590 USD
BDX
BDX
-0.820
(-0.48%)
171.380 USD
DGX
DGX
1.620
(0.96%)
171.200 USD
E
EXAS
0.490
(0.87%)
56.980 USD
P
PLRX
-0.06000
(-4.46%)
1.28500 USD
T
TAL
0.170
(1.57%)
11.000 USD
TMO
TMO
-6.77
(-1.69%)
393.52 USD
More
News

Title: Aditxt Inc

Sector: Healthcare
Industry: Biotechnology
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.